A B2B #socialmediamarketing manager by day and a #geekymom 24/7. *Views on this site reflect my personal opinions & do not represent the views of my employer*
Hi folks! 👋
After two days of sorting and filtering all my @BABSCon 2024 photos, I can announce a final total amount of 1.935 photos! 😊
The link to to them are coming soon. Stay tuned. 🫡📸
#XTBABS24#BABSCon2024
THANK YOU to @BABSCon for an incredible weekend! It was an honor to play the lead mascot role of Whinny Wonka🎫🍫 (aka Golden Gates), I thoroughly enjoyed collaborating with the talented cast and crew 💖 See you next year, my friends! 🦄 #BABSCon#mlp#mlpcosplay#mylittlepony
I'm so thrilled to be here at @PoniExpo here with Queen @Elley_Ray ! And even more excited that I was able to get these CUTIES in from charity Tender Little 💖 Hearts! #mlp#pinkiepie#minipony#mylittlepony
We’re at the White House today to support the #CancerMoonshot call to action on cancer screenings. Our moonshot is to advance health equity for #colorectalcancer patients by helping to close the screening gap and advocating for policy changes. #MyCancerMoonshot#StrongArmSelfie
This is it, the final hour of the #AUA22 expo show floor. Definitely stop by our Booth 647 to meet with our amazing staff to learn about our #Oncotype IQ® test portfolio. https://t.co/5DyXhFIFpl
#AUA22 Grab your spot at the St. Charles Ballroom in the Hilton New Orleans Riverside as Dr. Daniel Shoskes gives insight about the #Oncotype DX Genomic Prostate Score® NOW at the USAV Presentation!
Check out the new GPS Result Explorer! Learn how the #Oncotype DX® GPS™ assay can be used to help refine patient risk levels for more informed treatment decisions with this new tool. #AUA22#prostatecancer https://t.co/0Ms7qGnREw
Dr. Daniel Shoskes will be presenting at the USAV Presentation at #AUA22 on, "Performance of the #Oncotype DX Genomic Prostate Score® in African American Patients with Localized #ProstateCancer." Add this to your calendar here 👉https://t.co/sZChse0WSc
#AUA22 is where you will learn how the #Oncotype DX® GPS™ assay is a genomic assay designed for men with low-, intermediate-, and high-risk localized #prostatecancer to help guide treatment decisions. Booth 647 https://t.co/sGDPQ5fVNC